MIRA
INFORM REPORT
|
Report Date : |
22.11.2006 |
IDENTIFICATION
DETAILS
|
Name : |
PLUTO
INTERNATIONAL |
|
|
|
|
Registered Office : |
B –
411, Mangal Arambh, Off. S V Road, Next to Mc Donald, Borivali – 400092 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2006 |
|
|
|
|
Date of Incorporation : |
1999 |
|
|
|
|
Legal Form : |
Partnership
concern with an unlimited liability of the partner |
|
|
|
|
Line of Business : |
Indenting
Agents for Pharmaceutical Raw Materials, Bulk Drugs and Chemicals. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
Maximum Credit Limit : |
|
|
|
|
|
Status : |
Satisfactory
|
|
|
|
|
Payment Behaviour : |
Usually
Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject
is an established indenting house working on commission basis. Trade
relations are fair. Payments are usually correct and as per commitments. The
concern has steady business. It can
be considered for normal business dealings at usual trade terms and
conditions. |
LOCATIONS
|
Registered Office : |
B –
411, Mangal Arambh, Off. S V Road, Next to Mc Donald, Borivali – 400092 |
|
Tel. No.: |
91-22-28994607 |
|
Mobile No.: |
9820708842-41 |
|
Fax No.: |
91-22-28997420 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
225
Sq. ft |
|
Location : |
Owned |
PARTNERS
|
Name : |
Mr.
Rajan Joshi |
|
Designation : |
Partner |
|
Date of Birth/Age : |
30
years |
|
Qualification : |
B.
Com. |
|
Experience : |
9
years |
|
|
|
|
Name : |
Mr.
Kinjal Dixit |
|
Designation : |
Partner |
|
Date of Birth/Age : |
31
years |
|
Qualification : |
Diploma
in Electronics |
|
Experience : |
7
years |
BUSINESS DETAILS
|
Line of Business : |
Indenting
Agents for Pharmaceutical Raw Materials, Bulk Drugs and Chemicals. |
|
|
|
|
Products : |
v
1-3 Dichloro Benzene v
1-3 Difluro Benzene v
1 4 Hydroquinine (Photograde 99%) v
1 6 Dehydro Pregnenclone Acetate v
1 Cyclopropyl 6, 7 Difluro 1 4 Dihydro 8 v
2 4 5 Trifluro 3 Methoxy Benzoic Acid v
2 4 Dichloro 5 Fluro Aceto Phenone v
2 4 Dichloro 5 Fluoro Benzene v
2 5 Dihydroxy 14 Dithiane v
2 6 Dichloro Benzaldehyde v
2 6 Dichloro Phenol 99% v
2 Aminothiazole 4 Methoxymino Acetate v
2 Cyano 4 Menthyl Biphenyl v
2 Fluoro Ethanol v
2 Thiophene Ethanol v
3 $ Dichloro Benzyl Chloride v
4 Bromo Methyl 2 Cyano Biphenyl v
4 Chloro 2 (Z) Methoxy Carbonyl v
Methox v
4 Methyl Cyclo Hexyl Isocycanate v
Acrolein v
Acetophenone v
L Alanini v
Aceto Acet Mxylidide v
Cyclo Propylamine v
Cysteamme HCL 95% v
23456 Pentafluro Benzoic Acid v
2 Acetyl Furan v
2 Amino 5 Methyl Pyridine v
2 Methyl Pentanal 98% v
2 Propenal 2 Methyl Pental v
2 Methyl Piperazine v
8 Hydroxy Quinoline 99.5% v
8 Methoxy 6 7 Difluro 1 Cyclopropyl v
Diethyl Malonate 99.7% v
Di Methyl Carbonate v
Immino Stil Bene Carbonyl Chloride v
2 4 Difluro Nitro Benzene 99% v
Emme 99% v
Alpha Ltpoic Acid 99.5% v
2
amino butanole dl v
6
amino penicillianic acid (6 apa) v
Benzo
Quinone v
1
4 Bromo Fluro Benzene v
2
Chloro Nicotinic Acid v
2
3 4 6 1 4 Dichloro Dicyano Benzo Quinone v
Di
Fluro Methoxy v
Di
Hydroxy Benzoic Acid 3 5 v
Mercapto
Benzothiazolyl Amino Thiazoleyl Methoxy Imino 224 v
Mercapto
Methyl Thiadiazole 25134 v
Methoxy
Imino Amino Thiazolyl Acetic Acid v
Methoxy
Imino Furylyl Acetic Acid Ammonium v
Salt
Smia 2222 v
Do
Acid Ammonium Salt Smia 2222 v
Morpholine Oxohydroxy
Mercapto v
Methyl
Dihydro 563225124 v
Parahydroxy
Phenyl Glycine Base v
Piperacillin
Acid v
Pyrrole
99.5 % v
2
Pyrrolidone v
Tetrazole
Acetic Acid 11 v
CIS
Dibenzyl Oxo Imidazolidine Di Carboxylic v
Acid
12345 v
3
4 Di Fluro Notrobenzene 99.5 % v
Di
Hydro Phenyl Glycine Methyl Sodium Dane Salt v
Di
Methoxy Benzene Veratrole 99 % v
Di
Methly Amino Propyl Chloride HCL 3 v
Di
Thiane Dihydroxy v
Imino
Dibenzyl v
l
proline v
Methyl
biphenyl |
GENERAL
INFORMATION
|
Customers : |
Wholesalers
and End users |
|
|
|
|
No. of Employees : |
1 |
|
|
|
|
Bankers : |
State
Bank of India, Borivali (West), Mumbai – 400092 |
|
|
|
|
Facilities : |
-- |
|
|
|
|
Banking Relations : |
Satisfactory
|
|
|
|
|
Associates/Subsidiaries : |
Nil |
CAPITAL STRUCTURE
|
Capital
Investment : |
|
|
Owned : |
Rs.
0.500 Millions |
|
Borrowed : |
-- |
|
Total : |
Rs.
0.500 Millions |
FINANCIAL DATA
[all figures are in Rupees
Millions]
|
Particulars |
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
Commission Earring |
2.000 |
1.800 |
1.200 |
Expected
Sales March 2007 – Rs. 2.200 Millions
LOCAL AGENCY
FURTHER INFORMATION
The
concern shifted its office to new address sometime back
It is in
trade terms with :-
Ř
Shree
Rajchem
Malad (West), Mumbai, Maharashtra
Contact Person : Mahendra Jatakia
Tel. No. 91-22-28816688
Ř
Vidhya
Pharma Chem Private Limited
Borivali, Mumbai – 400092, Maharashtra
Contact Person : Mr. Mahendra Jain
Tel. No. 91-22-28021902
CMT REPORT [Corruption, Money
laundering & Terrorism]
The
Public Notice information has been collected from various sources including but
not limited to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION
ON DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or anti-terrorism
sanction laws or whose assets were seized, blocked, frozen or ordered forfeited
for violation of money laundering or international anti-terrorism laws.
2] Court
Declaration :
No records exist to suggest that subject is or was the subject of any formal
or informal allegations, prosecutions or other official proceeding for making
any prohibited payments or other improper payments to government officials for
engaging in prohibited transactions or with designated parties.
3] Asset
Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record
on Financial Crime :
Charges or conviction registered
against subject: None
5] Records
on Violation of Anti-Corruption Laws :
Charges or investigation registered
against subject: None
6] Records
on Int’l Anti-Money Laundering Laws/Standards :
Charges or investigation registered
against subject: None
7] Criminal
Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation
with Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation
Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA
INFORM as part of its Due Diligence do provide comments on Corporate Governance
to identify management and governance. These factors often have been predictive
and in some cases have created vulnerabilities to credit deterioration.
Our
Governance Assessment focuses principally on the interactions between a
company’s management, its Board of Directors, Shareholders and other financial
stakeholders.
CONTRAVENTION
Subject
is not known to have contravened any existing local laws, regulations or
policies that prohibit, restrict or otherwise affect the terms and conditions
that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US
Dollar |
1 |
Rs.44.99 |
|
UK
Pound |
1 |
Rs.85.34 |
|
Euro |
1 |
Rs.57.63 |
SCORE &
RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit
history (10%) Market
trend (10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors
carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we
have no basis upon which to recommend credit dealings |
No Rating |
|